ICU Medical Investor Presentation — May 2024

Document content

Q1 2024 Conference Call

May 7, 2024Disclosures

>Any statement concerning Management’s expectation with respect to future results is a forward -looking statement based

upon the best information currently available to Management and assumptions Management believes are reasonable,

but Management does not intend the statement to be a representation as to future results.

>Future results are subject to risks and uncertainties, including the risk factors described in the Company’s filings with the

Securities and Exchange Commission, which include those in the most recent Form 10 -K and subsequent filings. Actual

results in the future may differ materially from Management’s current expectations.

>These forward -looking statements, including statements about continuing health crises, pandemics and epidemics, such

as the COVID -19 pandemic, are made based upon our current expectations and we undertake no duty to update

information provided in this presentation.

>This presentation contains financial measures that are not calculated in accordance with U.S. generally accepted

accounting principles ("GAAP"). These non -GAAP financial measures should be considered supplemental to, and not as

a substitute for, or superior to, financial measures calculated in accordance with GAAP. Our management believes that

the non -GAAP data provides useful supplemental information to management and investors regarding our performance

and facilitates a more meaningful comparison of results of operations between current and prior periods.

>Our non -GAAP financial measures include revenue presented on a constant currency basis, which uses the average

exchange rate for revenues from the prior year applied to the current year results.

22023 –2024 Adjusted Revenue

In $ millions, unaudited